^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

TRAIL R1 agonist

Phase 1
AbbVie
Completed
Last update posted :
12/09/2022
Initiation :
03/20/2017
Primary completion :
01/21/2022
Completion :
01/21/2022
KRAS
|
KRAS mutation • RAS mutation
|
Avastin (bevacizumab) • Venclexta (venetoclax) • 5-fluorouracil • irinotecan • leucovorin calcium • eftozanermin alfa (ABBV-621)
Phase 3
Shanghai Gebaide Biotechnology Co., Ltd.
Unknown status
Last update posted :
03/20/2017
Initiation :
10/01/2016
Primary completion :
10/01/2017
Completion :
06/01/2018
ALK
|
EGFR mutation • ALK positive • ALK mutation • EGFR positive • EGFR negative
|
dulanermin (AMG 951)